Latest Insider Transactions at Entrada Therapeutics, Inc. (TRDA)
This section provides a real-time view of insider transactions for Entrada Therapeutics, Inc. (TRDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Entrada Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Entrada Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
21,787
-0.49%
|
$435,740
$20.23 P/Share
|
|
Dec 11
2024
|
Mpm Bioventures 2018, L.P. |
SELL
Open market or private sale
|
Indirect |
21,787
-0.49%
|
$435,740
$20.23 P/Share
|
|
Dec 10
2024
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
22,935
-0.52%
|
$458,700
$20.77 P/Share
|
|
Dec 10
2024
|
Mpm Bioventures 2018, L.P. |
SELL
Open market or private sale
|
Indirect |
22,935
-0.52%
|
$458,700
$20.77 P/Share
|
|
Dec 03
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
11,703
-7.47%
|
$234,060
$20.15 P/Share
|
|
Dec 02
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
4,088
-2.54%
|
$81,760
$20.26 P/Share
|
|
Dec 02
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.34%
|
$100,000
$20.0 P/Share
|
|
Dec 02
2024
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.96%
|
$10,000
$2.1 P/Share
|
|
Nov 29
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$2,000
$20.0 P/Share
|
|
Nov 29
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.34%
|
$19,000
$19.97 P/Share
|
|
Nov 29
2024
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.32%
|
$2,000
$2.1 P/Share
|
|
Nov 13
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
2,700
-1.65%
|
$54,000
$20.04 P/Share
|
|
Nov 11
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,637
-10.47%
|
$164,103
$19.98 P/Share
|
|
Nov 11
2024
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+6.78%
|
$12,000
$2.1 P/Share
|
|
Nov 11
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
1,409
-0.85%
|
$28,180
$20.01 P/Share
|
|
Nov 06
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
12,299
-3.51%
|
$233,681
$19.01 P/Share
|
|
Nov 05
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
5,171
-2.83%
|
$93,078
$18.18 P/Share
|
|
Nov 04
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
749
-0.41%
|
$13,482
$18.02 P/Share
|
|
Oct 16
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
600
-0.33%
|
$10,800
$18.0 P/Share
|
|
Sep 26
2024
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
847
-0.67%
|
$13,552
$16.0 P/Share
|
|
Sep 09
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,195
-4.01%
|
$44,730
$14.97 P/Share
|
|
Sep 09
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
2,642
-1.42%
|
$39,630
$15.09 P/Share
|
|
Sep 09
2024
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
1,904
-1.49%
|
$28,560
$15.07 P/Share
|
|
Sep 06
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
600
-0.32%
|
$9,000
$15.24 P/Share
|
|
Sep 06
2024
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
399
-0.31%
|
$5,985
$15.19 P/Share
|
|
Sep 05
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-0.21%
|
$2,475
$15.13 P/Share
|
|
Sep 05
2024
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
826
-0.25%
|
$12,390
$15.13 P/Share
|
|
Sep 05
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
167
-0.09%
|
$2,505
$15.13 P/Share
|
|
Sep 05
2024
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-0.13%
|
$2,565
$15.13 P/Share
|
|
Sep 04
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
941
-1.16%
|
$14,115
$15.42 P/Share
|
|
Sep 04
2024
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,744
-1.43%
|
$71,160
$15.42 P/Share
|
|
Sep 04
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
955
-0.51%
|
$14,325
$15.42 P/Share
|
|
Sep 04
2024
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
983
-0.76%
|
$14,745
$15.42 P/Share
|
|
Sep 03
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
625
-0.26%
|
$10,000
$16.8 P/Share
|
|
Sep 03
2024
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,152
-0.31%
|
$50,432
$16.8 P/Share
|
|
Sep 03
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
634
-0.11%
|
$10,144
$16.8 P/Share
|
|
Sep 03
2024
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
654
-0.17%
|
$10,464
$16.8 P/Share
|
|
Aug 16
2024
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
27,097
-8.65%
|
$433,552
$16.48 P/Share
|
|
Aug 16
2024
|
Nathan J Dowden President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+11.29%
|
$20,000
$1.74 P/Share
|
|
Jul 15
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,600
-0.48%
|
$27,200
$17.81 P/Share
|
|
Jul 15
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
638
-0.34%
|
$11,484
$18.0 P/Share
|
|
Jul 12
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
300
-0.09%
|
$5,400
$18.0 P/Share
|
|
Jul 12
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
600
-0.32%
|
$10,800
$18.0 P/Share
|
|
Jul 08
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,758
-2.11%
|
$24,612
$14.95 P/Share
|
|
Jun 13
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.3%
|
$16,000
$16.17 P/Share
|
|
Jun 03
2024
|
Peter S Kim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,918
+10.25%
|
$71,508
$6.06 P/Share
|
|
May 20
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
9,675
-4.84%
|
$145,125
$15.19 P/Share
|
|
May 17
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
8,305
-3.99%
|
$124,575
$15.14 P/Share
|
|
May 17
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,200
-0.35%
|
$18,000
$15.11 P/Share
|
|
May 16
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
1,000
-0.48%
|
$15,000
$15.0 P/Share
|